SCINAI IMMUNOTHERAPEUTICS LT (SCNI)

US09073Q3039 - ADR

3.4414  +0.02 (+0.63%)

After market: 3.4 -0.04 (-1.2%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
452.00K0.000.000.000.00
Operating Expenses
9.69M9.71M11.06M10.78M-2.13M
Research and Development
6.39M5.21M5.76M2.62M14.42M
Selling, General, and Administrative Expenses
3.46M4.50M5.30M7.42M4.69M
Operating Income
-10.10M-9.71M-11.06M-10.78M2.13M
Interest Income/Expense
-2.12M3.21M5.26M-1.59M-3.43M
Income Before Taxes
2.54M-6.50M-5.80M-12.38M-1.30M
Net Income
2.54M-6.50M-5.80M-12.38M-1.30M
EBITDA
-8.87M-9.19M-10.50M-10.04M2.84M
 
Per Share Data
EPS Diluted Total Ops
3.520.00-39.56-870.27-118.67
Non GAAP EPS
N/A-18.70N/AN/AN/A
 
Statistics
Profit Margin
561.28%N/AN/AN/AN/A
Operating Profit Margin
-2234.29%N/AN/AN/AN/A

All data in USD

Charts